Second generation androgen receptor antagonists and challenges in prostate cancer treatment

Prostate cancer is a hormone-dependent malignancy, whose onset and progression are closely related to the activity of the androgen receptor (AR) signaling pathway. Due to this critical role of AR signaling in driving prostate cancer, therapy targeting the AR pathway has been the mainstay strategy fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yanhua, Zhou, Qianqian, Hankey, William, Fang, Xiaosheng, Yuan, Fuwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304354/
https://www.ncbi.nlm.nih.gov/pubmed/35864113
http://dx.doi.org/10.1038/s41419-022-05084-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304354/
https://www.ncbi.nlm.nih.gov/pubmed/35864113
http://dx.doi.org/10.1038/s41419-022-05084-1

Ejemplares similares